VERTEX PHARMACEUTICALS INC (VX1.DE) Stock Earnings & Estimates
Europe - Frankfurt Stock Exchange - FRA:VX1 - US92532F1003 - Common Stock
394.9 EUR
+5.05 (+1.3%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 8.931B 17.91% | 9.869B 10.51% | 11.02B 11.66% | 12.233B 11.01% | 13.302B 8.74% | 14.533B 9.25% | 16.003B 10.11% | 17.648B 10.28% | 19.118B 8.33% | 19.843B 3.79% | 21.27B 7.19% | |
| EBITDA YoY % growth | 4.584B 57.66% | 4.54B -0.96% | 4.603B 1.37% | 5.49B 19.28% | 6.368B 15.99% | 7.164B 12.50% | 7.474B 4.33% | 8.268B 10.62% | 8.99B 8.73% | 9.705B 7.95% | 10.834B 11.63% | |
| EBIT YoY % growth | 4.436B 59.44% | 4.359B -1.73% | 4.396B 0.84% | 5.338B 21.44% | 6.106B 14.39% | 6.884B 12.74% | 7.572B 9.99% | 8.57B 13.18% | 9.217B 7.55% | 9.975B 8.22% | 10.812B 8.39% | |
| Operating Margin | 49.67% | 44.17% | 39.89% | 43.64% | 45.90% | 47.37% | 47.32% | 48.56% | 48.21% | 50.27% | 50.83% | |
| EPS YoY % growth | 14.89 14.36% | 15.22 2.22% | 0.29 -98.09% | 18.69 6,343.89% | 20.45 9.43% | 22.88 11.88% | 25.06 9.54% | 28.52 13.80% | 30.79 7.96% | 33.44 8.60% | 36.96 10.53% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 5.21 30.83% | 4.93 21.49% | 5.06 12.05% | 5.18 7.90% | 5.24 0.58% |
| Revenue Q2Q % growth | 3.244B 11.40% | 3.182B 14.87% | 3.282B 10.70% | 3.343B 8.67% | 3.389B 4.47% |
| EBITDA Q2Q % growth | 1.476B 11.76% | 1.61B 49.45% | 1.562B 24.62% | 1.567B 12.35% | 1.491B 1.02% |
| EBIT Q2Q % growth | 1.465B 31.57% | 1.454B 41.32% | 1.466B 27.11% | 1.469B 18.40% | 1.473B 0.55% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 4.80 9.59% | 4.65 | 0.15 | 3.12% |
| Q2 2025 Q2Q % growth | 4.52 135.23% | 4.37 | 0.15 | 3.45% |
| Q1 2025 Q2Q % growth | 4.06 -14.71% | 4.37 | -0.31 | -7.20% |
| Q4 2024 Q2Q % growth | 3.98 -5.24% | 4.11 | -0.13 | -3.07% |
| Q3 2024 Q2Q % growth | 4.38 7.35% | 4.22 | 0.16 | 3.69% |
| Q2 2024 Q2Q % growth | -12.83 -429.82% | 3.00 | -15.83 | -527.57% |
| Q1 2024 Q2Q % growth | 4.76 56.07% | 4.14 | 0.62 | 14.85% |
| Q4 2023 Q2Q % growth | 4.20 11.70% | 4.18 | 0.02 | 0.36% |
| Q3 2023 Q2Q % growth | 4.08 1.75% | 4.05 | 0.03 | 0.66% |
| Q2 2023 Q2Q % growth | 3.89 8.06% | 3.96 | -0.07 | -1.75% |
| Q1 2023 Q2Q % growth | 3.05 -13.35% | 3.06 | -0.01 | -0.21% |
| Q4 2022 Q2Q % growth | 3.76 11.57% | 3.58 | 0.18 | 4.95% |
| Q3 2022 Q2Q % growth | 4.01 12.64% | 3.72 | 0.29 | 7.89% |
| Q2 2022 Q2Q % growth | 3.60 15.76% | 3.55 | 0.05 | 1.44% |
| Q1 2022 Q2Q % growth | 3.52 18.12% | 3.56 | -0.04 | -1.18% |
| Q4 2021 Q2Q % growth | 3.37 34.26% | 3.37 | 0.00 | 0.13% |
| Q3 2021 Q2Q % growth | 3.56 34.85% | 3.14 | 0.42 | 13.27% |
| Q2 2021 Q2Q % growth | 3.11 19.16% | 2.56 | 0.55 | 21.59% |
| Q1 2021 Q2Q % growth | 2.98 16.41% | 2.74 | 0.24 | 8.66% |
| Q4 2020 Q2Q % growth | 2.51 47.65% | 2.64 | -0.13 | -5.00% |
| Q3 2020 Q2Q % growth | 2.64 114.63% | 2.39 | 0.25 | 10.49% |
| Q2 2020 Q2Q % growth | 2.61 107.14% | 2.12 | 0.49 | 23.38% |
| Q1 2020 Q2Q % growth | 2.56 124.56% | 1.88 | 0.68 | 36.03% |
| Q4 2019 Q2Q % growth | 1.70 | 1.23 | 0.47 | 38.03% |
| Q3 2019 Q2Q % growth | 1.23 | 1.17 | 0.06 | 4.95% |
| Q2 2019 Q2Q % growth | 1.26 | 1.09 | 0.17 | 15.76% |
| Q1 2019 Q2Q % growth | 1.14 | 0.99 | 0.15 | 14.85% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 3.076B 10.99% | 3.114B | -37.6M | -1.21% |
| Q2 2025 Q2Q % growth | 2.965B 12.06% | 2.963B | 1.7M | 0.06% |
| Q1 2025 Q2Q % growth | 2.77B 2.96% | 2.91B | -139.8M | -4.80% |
| Q4 2024 Q2Q % growth | 2.912B 15.66% | 2.836B | 76M | 2.68% |
| Q3 2024 Q2Q % growth | 2.772B 11.61% | 2.778B | -6.1M | -0.22% |
| Q2 2024 Q2Q % growth | 2.646B 6.11% | 2.715B | -69.4M | -2.56% |
| Q1 2024 Q2Q % growth | 2.691B 13.30% | 2.63B | 60.6M | 2.30% |
| Q4 2023 Q2Q % growth | 2.518B 9.34% | 2.564B | -46.3M | -1.81% |
| Q3 2023 Q2Q % growth | 2.484B 6.39% | 2.55B | -66.5M | -2.61% |
| Q2 2023 Q2Q % growth | 2.493B 13.52% | 2.468B | 25.2M | 1.02% |
| Q1 2023 Q2Q % growth | 2.375B 13.22% | 2.384B | -9.2M | -0.39% |
| Q4 2022 Q2Q % growth | 2.303B 11.10% | 2.347B | -44.3M | -1.89% |
| Q3 2022 Q2Q % growth | 2.334B 17.65% | 2.271B | 63.3M | 2.79% |
| Q2 2022 Q2Q % growth | 2.196B 22.46% | 2.175B | 21.2M | 0.97% |
| Q1 2022 Q2Q % growth | 2.098B 21.64% | 2.118B | -20.5M | -0.97% |
| Q4 2021 Q2Q % growth | 2.073B 27.32% | 2.043B | 29.561M | 1.45% |
| Q3 2021 Q2Q % growth | 1.984B 28.99% | 1.893B | 91.164M | 4.82% |
| Q2 2021 Q2Q % growth | 1.793B 17.64% | 1.752B | 41.37M | 2.36% |
| Q1 2021 Q2Q % growth | 1.724B 13.81% | 1.69B | 34.305M | 2.03% |
| Q4 2020 Q2Q % growth | 1.628B 15.18% | 1.616B | 11.82M | 0.73% |
| Q3 2020 Q2Q % growth | 1.538B 61.95% | 1.515B | 23.271M | 1.54% |
| Q2 2020 Q2Q % growth | 1.524B 61.96% | 1.413B | 111.485M | 7.89% |
| Q1 2020 Q2Q % growth | 1.515B 76.50% | 1.313B | 202.107M | 15.39% |
| Q4 2019 Q2Q % growth | 1.413B | 1.033B | 380.265M | 36.81% |
| Q3 2019 Q2Q % growth | 949.828M | 969.92M | -20.092M | -2.07% |
| Q2 2019 Q2Q % growth | 941.293M | 903.29M | 38.003M | 4.21% |
| Q1 2019 Q2Q % growth | 858.435M | 867.48M | -9.045M | -1.04% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.05% | 2.35% | 1.67% | 1.53% |
| Revenue | 0% | -0.83% | 0.05% | 0.1% |